Want to see IN:INNOVACAP full AI Analyst Report?

Innova Captab Limited (INNOVACAP) Price & Analysis

0 Followers

INNOVACAP Stock Chart & Stats

₹957.45

₹7.35(0.77%)

At close: Jul 29 4:00 PM EDT

₹957.45

₹7.35(0.77%)

Day’s Range― - ―

52-Week Range₹608.25 - ₹1,033.00

Previous CloseN/A

Volume8.81K

Average Volume (3M)1.70K

Market Cap

₹55.77B

Enterprise Value₹56.90B

Total Cash (Recent Filing)₹451.54M

Total Debt (Recent Filing)₹3.44B

Price to Earnings (P/E)39.6

Beta0.87

Next Earnings

Aug 07, 2026

EPS Estimate

3.4

Next Dividend Ex-DateN/A

Dividend Yield0.2%

Share Statistics

EPS (TTM)24.62

Shares Outstanding57,224,930

10 Day Avg. Volume1,138

30 Day Avg. Volume1,704

Financial Highlights & Ratios

PEG Ratio2.83

Price to Book (P/B)3.62

Price to Sales (P/S)2.46

P/FCF Ratio114.94

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)33.2

Revenue Forecast (FY)₹19.82B

Bulls Say, Bears Say

Bulls Say

Strong Revenue GrowthSustained high revenue growth (31% recent rate) indicates the company is expanding market share and product uptake across dosage forms. Durable top-line momentum supports operating leverage, capacity utilization and long-term investment in manufacturing and exports over the next several months.

Solid ProfitabilityConsistent operating and net margins with rising net income provide a durable earnings base that funds reinvestment and supports return metrics. Solid profitability helps the company absorb cost shocks, sustain R&D/manufacturing spend, and maintain shareholder returns over a multi-month horizon.

Improving Leverage And Equity BaseAn improving debt-to-equity profile and expanding equity base reduce refinancing and covenant risk while increasing financial flexibility. This stronger balance-sheet footing supports capital investments, export growth and resilience to industry cycles over the medium term.

Bears Say

Weak Free Cash FlowRepeated negative free cash flow signals the business struggles to convert reported profits into cash, limiting self-funded growth and increasing reliance on external financing. Over months this can constrain capex, delay strategic projects, and raise execution risk despite strong reported earnings.

Light Operating Cash Vs EarningsOperating cash lagging earnings reduces earnings quality and suggests accruals or working-capital strain. If cash conversion fails to improve, the company may face pressure to raise funds or cut investment, which undermines durable growth prospects and increases vulnerability to margin shocks.

Gross Margin VolatilityFluctuating gross margins point to pricing, mix or input-cost pressures that can persist and compress long-term profitability. Margin instability complicates forecasting, weakens return consistency, and may force trade-offs between market share and margin maintenance over the coming months.

Innova Captab Limited News

Innova Captab Sets Fully Virtual AGM With Remote E-Voting for June 29

An update from Innova Captab Limited ( ($IN:INNOVACAP) ) is now available. Innova Captab Limited has announced that...

2M ago

Innova Captab Files SEBI Compliance Certificate, Reports No Share Demat Changes in Q4 FY26

Innova Captab Limited ( ($IN:INNOVACAP) ) has provided an update. Innova Captab Limited has submitted to Indian stock...

4M ago

Innova Captab to Review Q3 FY26 Results and Consider Interim Dividend on 23 January

The latest update is out from Innova Captab Limited ( ($IN:INNOVACAP) ). Innova Captab Limited has scheduled a...

7M ago

Innova Captab’s Jammu Facility Recommended for GMP Certification by Ukraine

Innova Captab Limited ( ($IN:INNOVACAP) ) has shared an announcement. Innova Captab Limited announced that its manufacturing facility...

10M ago

Innova Captab’s Baddi Plant Passes UK-MHRA Inspection

The latest announcement is out from Innova Captab Limited ( ($IN:INNOVACAP) ). Innova Captab Limited has successfully completed...

12M ago

Innova Captab to Engage with Investors at Upcoming Conference

The latest announcement is out from Innova Captab Limited ( ($IN:INNOVACAP) ). Innova Captab Limited has announced its...

1y ago

INNOVACAP FAQ

What was Innova Captab Limited’s price range in the past 12 months?

Innova Captab Limited lowest stock price was ₹608.25 and its highest was ₹1033.00 in the past 12 months.

What is Innova Captab Limited’s market cap?

Innova Captab Limited’s market cap is ₹55.77B.

When is Innova Captab Limited’s upcoming earnings report date?

Innova Captab Limited’s upcoming earnings report date is Aug 07, 2026 which is in 2 days.

How were Innova Captab Limited’s earnings last quarter?

Innova Captab Limited released its earnings results on May 07, 2026. The company reported ₹3.3 earnings per share for the quarter, beating the consensus estimate of N/A by ₹3.3.

Is Innova Captab Limited overvalued?

According to Wall Street analysts Innova Captab Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Innova Captab Limited pay dividends?

Innova Captab Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 0.2%. See more information on Innova Captab Limited dividends here

What is Innova Captab Limited’s EPS estimate?

Innova Captab Limited’s EPS estimate is 3.4.

How many shares outstanding does Innova Captab Limited have?

Innova Captab Limited has 57,224,930 shares outstanding.

What happened to Innova Captab Limited’s price movement after its last earnings report?

Innova Captab Limited reported an EPS of ₹3.3 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.422%.

Which hedge fund is a major shareholder of Innova Captab Limited?

Currently, no hedge funds are holding shares in IN:INNOVACAP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Innova Captab Limited

Innova Captab Limited, established in Panchkula, India, in 2005, operates as a comprehensive pharmaceutical enterprise. Its operations encompass the full spectrum of drug development, from research and development and manufacturing to distribution and marketing, serving both domestic and international markets. The company also extends Contract Development and Manufacturing Organization (CDMO) services to other pharmaceutical businesses within India. Furthermore, Innova Captab is actively involved in developing, producing, and supplying a diverse array of generic medications. These formulations address a broad range of therapeutic areas, including anti-infectives (such as cephalosporins and antivirals), gastrointestinal treatments (like proton pump inhibitors and antiemetics), pain and inflammation management (including NSAIDs and analgesics), respiratory and allergy relief, cardiovascular support, antidiabetics, various neurological and psychiatric therapies, and solutions for urological conditions, among numerous other specialized segments. These pharmaceutical offerings are provided in multiple forms, such as tablets, capsules, dry syrups, injectable powders, ointments, and liquid oral preparations. Innova Captab distributes its branded generic products through an extensive network of distributors and pharmacies, in addition to utilizing various online e-commerce pharmacy platforms.